- Search News
- Dreyfus-Teacher Scholar Award for Szymczak
- Sanford Named to AAAS
- Biemann Medal for Hakansson
- Sanford Honored with Election to National Academy of Sciences
- McNeil Lab: A more accurate sensor for lead paint
- Schindler Named 2016 Packard Fellow
- Sloan Fellowships for Pratt and Schindler
- Walter Lab: Resolving Subcellular miRNA Trafficking and Turnover at Single-Molecule Resolution
- Maldonado Lab: Cheaper, greener way to grow cystalline semiconductor films
- New polymer allows researchers to study how proteins fold, function
- Researchers focus on cell membranes to develop Alzheimer's treatments
- Video: Research on Lipid Bilayer and Relation to Amyloid-β
- Biteen Lab: Accounting for the "scooching effect"
- Pratt Lab: Molecular Iodine Found in Arctic Atmosphere
- Marsh & McNeil Named AAAS Fellows
- Ramamoorthy Lab: Nanodiscs catch mis-folding amyloid proteins
- Ault Named 2018 Sloan Fellow
- Biteen Lab: Starch Utilization System Assembles around Stationary Starch-Binding Proteins
- Biteen Lab: Starch Utilization System Assembles around Stationary Starch-Binding Proteins
- Pratt & Ault Labs: Harmful algal blooms can become airborne
- Meet Professor Bunsen Burns
- Shedding New Light on Photosynthetic Pigments
- Ruotolo Lab: New Method to ID Proteins
- Energy Research And Education Fuel McCrory CAREER Award
- Building Motors to Drive Nanorobots
- Fast, sensitive mass spectrometer will help UM chemists profile proteins and metabolites
- Award Season for Michigan Chemistry
- Chem Alum Receives Honorary Degree, Gives Rackham Commencement Address
- Alum Named Science Teacher of the Year
- MichiganChem boosts facility for atomic resolution
- DOE Early Career Award for Kerri Pratt
- ACS Honors Alum Weihong Tan
- Michigan Adds Chemistry Education Faculty Position
- Mapp Lab: New research clarifies how ‘fuzzy’ proteins can be used to develop novel drugs
- Karle Symposium Showcases Our Innovative Research
- UM scientists improve synthesis of PET imaging molecules
- MichiganChem Goes to the North Pole
- Diversity Service Award for Nicolai Lehnert
- Two elected Fellows of Royal Society of Chemistry
- Graduate Student Coordinator Honored
- 2018 Mentoring Award Recognizes Unique Programs
- Chen Named AAAS Fellow
- Chem 211 makes organic chem lab real for intro students
- Stephenson Lab: Designing a safer drug building block through photocatalysis
- "Compute-To-Learn" Bridges Classroom to Real-World Experiences
- Meet Roy Wentz: Chemistry's Custom Glassblower
- Michigan Students to Organize American Chemical Society Grad Symposium
- Anna Mapp honored for exceptional efforts to recruit and mentor students from non-traditional backgrounds
- Chemistry Alums Boyd and Pérez-Temprano Named to Talented 12
- Sharing Chemistry with the Community
- Awards Luncheon Offers Recognition for Outstanding Students
- Chemistry Faculty and Staff Collect Honors for Their Work
- Chemistry Writing: More Than Just Lab Reports
- Featured on the UM Gateway: Chemistry D-RISE Alum
- Hot climate, cool science :: Novel instrumentation applied to Arctic atmosphere earns Pratt "40 under 40" honors
- Kennedy Awarded Martin Medal for Achievements in Separation Science
- UM Chemists finding new opportunities in quantum science
- Alumna Sumita Mitra Inducted into National Inventors Hall of Fame
- Walter lab: RNA molecule senses a small metal ion to ramp up bacterium’s detox machine
- Create for Chemistry art contest
- Matzger Lab: A fix for insoluble drugs
- Dope Labs podcast explores the science behind pop culture phenomena
- Travel begets new data and new insights for Michigan Chem grad students
- Kopelman Lab: Nanoparticles + photoacoustic imaging-- a route to better cancer treatment decisions?
- Wang Lab: A productive first year
- National ACS Awards for Four Michigan Faculty
- Montgomery Named Thurnau Professor
- Mental Health, Well-Being and Research
- U-M to 3M: Transitioning to Industry after your PhD
- Chemistry Coping with COVID-19
- Chem Alums Create Crowdfunding Platform
- NSF Graduate Research Fellowships Announced
- Chem Master's Application Re-opened
- Chemistry Awards Announced
- New podcast: "My Fave Queer Chemist”
- Meet Josh Buss
- M|CORE: Preview program lowers barriers to graduate school
- Soellner Joins Michigan Chemistry
- Meet Chem Lecturer Nicole Tuttle
- Thank You for your support on Giving Blueday!
- Chemistry Researchers Apply Their Expertise to COVID-19
- Learning to RELATE
- Archived News
- UM Chemistry Featured Elsewhere
When you reach for a bottle of acetaminophen, you may be looking for relief from a headache. But if you take more than what is recommended, the drug can damage your liver.
That’s because when a component of the drug—a substructure referred to as an aniline—breaks down in the liver, it can produce toxic metabolites. Now, University of Michigan researchers have developed a new building block that can serve as a safer alternative for the development of new medicines.
The pharmaceutical industry commonly uses anilines as the basis for developing new drug therapies. But the way the liver metabolizes many drug therapies containing anilines can cause toxic side effects. For example, overloading the liver with acetaminophen can cause liver failure. Other drugs can trigger a harmful immune response in the body as a result of the unwanted metabolism.
“Aniline is a common structure that’s easy to make,” said Corey Stephenson, U-M professor of chemistry. “The problem with anilines is that they are readily metabolized by our liver, and that can create problems. We want our drugs to be metabolized, but not in a way that causes them to have toxic effects.”
Stephenson and his team’s research into developing a safer building block began as a desire to explore ways to use visible light to drive chemical reactions. The team began looking into structures called aminocyclopropanes, hoping to convert them into more complex and more valuable compounds.
The team recognized the potential to convert aminocyclopropanes into a different compound, a 1-aminonorbornane, which is more complex and traditionally very difficult to synthesize. The research team also realized that these 1-aminonorbornanes could be highly useful in discovering new drug leads.The benefit? 1-Aminonorbornanes don’t seem to be metabolized in harmful ways by liver enzymes.
“We realized that we can use these aminonorbornane cores as a substitute for an aniline,” said Daryl Staveness, a U-M postdoctoral researcher and American Cancer Society fellow. “Usually, drug companies will need to re-engineer drugs that use it to avoid that oxidation event. But in using aminonorbornanes, we don’t have to worry about those metabolic processing issues.”
The process the team used to convert aminocyclopropanes into the beneficial 1-aminonorbornane structures has another benefit: because the reaction needed to produce the molecule is powered by visible light, 1-aminonorbornanes can be produced cheaply, sustainably and on a large scale.
“It’s inexpensive. It’s mild,” said co-author and U-M graduate student Taylor Sodano. “Using traditional chemical approaches, 1-aminonorbornanes have been previously difficult to synthesize, requiring inefficient sequences of reactions and forcing inflexible conditions. Now, we can do it in one step at room temperature, using visible light and environmentally friendly conditions.”
To produce 1-aminonorbornanes, the team employed a photocatalyst to execute the desired transformation. Catalysts are compounds that facilitate a chemical reaction, and in the case of photoredox catalysis, the special brand of photochemistry the team used, the catalysts operate by using the energy of visible light to shuttle electrons between molecules.
When Sodano and Staveness mix their photocatalyst with an aminocyclopropane and expose the solution to LED lights, the catalyst takes an electron from the aminocyclopropane, initiating the process that produces the 1-aminonorbornane, which is still missing its electron. The catalyst then gives the electron back to complete the reaction. Nothing else needs to be added other than the light, making this process exceptionally environmentally benign.
Study co-author Klarissa Jackson of Lipscomb University studied the safety of the 1-aminonorbornanes. She applied the compounds to liver fragments containing the enzymes that typically metabolize drug compounds. She found that when the enzymes broke down the 1-aminonorbornanes, the process did not produce the harmful metabolites that result from anilines.
“People are always striving to generate safer and better medicines, and what we need from a chemistry standpoint are more tools to do that,” Stephenson said. “Additionally, we can combine sustainability with these new tools, so you get both an environmentally friendly way to produce these compounds, and the final products have the potential to have implications in human health.”
The team says the study is foundational work they are applying to a wide range of applications, ranging from epilepsy to hearing loss to cancer to fungicides. Additional co-authors include KJ Li and Elizabeth Burnham of Lipscomb University. The postdoctoral fellowship funding Staveness comes courtesy of the Michigan Cancer Research Fund.